Tumor Regression and Allograft Rejection after Administration of Anti-PD-1.
Tumor Regression and Allograft Rejection after Administration of Anti-PD-1.
Available online from MWHC library: 1993 - present, Available in print through MWHC library: 1980 - present
English
0028-4793
*Antineoplastic Agents/tu [Therapeutic Use]
*Carcinoma, Squamous Cell/dt [Drug Therapy]
*Graft Rejection/ci [Chemically Induced]
*Programmed Cell Death 1 Receptor/im [Immunology]
*Skin Neoplasms/dt [Drug Therapy]
Allografts
Carcinoma, Squamous Cell/sc [Secondary]
Female
Humans
Immunocompromised Host
Kidney Transplantation
Kidney/me [Metabolism]
Kidney/pa [Pathology]
Middle Aged
Programmed Cell Death 1 Receptor/ai [Antagonists & Inhibitors]
Programmed Cell Death 1 Receptor/me [Metabolism]
Skin Neoplasms/sc [Secondary]
MedStar Washington Hospital Center
Medicine/Nephrology
Case Reports
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Available online from MWHC library: 1993 - present, Available in print through MWHC library: 1980 - present
English
0028-4793
*Antineoplastic Agents/tu [Therapeutic Use]
*Carcinoma, Squamous Cell/dt [Drug Therapy]
*Graft Rejection/ci [Chemically Induced]
*Programmed Cell Death 1 Receptor/im [Immunology]
*Skin Neoplasms/dt [Drug Therapy]
Allografts
Carcinoma, Squamous Cell/sc [Secondary]
Female
Humans
Immunocompromised Host
Kidney Transplantation
Kidney/me [Metabolism]
Kidney/pa [Pathology]
Middle Aged
Programmed Cell Death 1 Receptor/ai [Antagonists & Inhibitors]
Programmed Cell Death 1 Receptor/me [Metabolism]
Skin Neoplasms/sc [Secondary]
MedStar Washington Hospital Center
Medicine/Nephrology
Case Reports
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't